arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Celcuity Inc.

CELC
$92.79 ▼ -0.54 (-0.58%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
40 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Celcuity Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $5.1B
Dividend Yield
Revenue Growth
Op. Margin
ROIC -20.8%
FCF / Share $-1.02
Trailing P/E
Price / Book 83.8x
FCF Yield
Debt / Equity 2.58
info Valuation on last close. End-of-day price, Aug 7, 2026.

40-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-52.84M
↓ -42.8%
FCF / Share Free cash flow per share
$-1.02
↓ -21.8%
Long-Term Debt Long-term obligations
$137.87M
— +0.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
3
Financial Health
24
Cash Quality
58

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 40 quarters